GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (STU:1A80) » Definitions » E10

Accelerate Diagnostics (STU:1A80) E10 : €-11.83 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Accelerate Diagnostics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Accelerate Diagnostics's adjusted earnings per share data for the three months ended in Sep. 2024 was €-0.532. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-11.83 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was -8.90% per year. During the past 5 years, the average E10 Growth Rate was -13.80% per year. During the past 10 years, the average E10 Growth Rate was -21.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Accelerate Diagnostics was 6.80% per year. The lowest was -49.60% per year. And the median was -23.50% per year.

As of today (2024-12-13), Accelerate Diagnostics's current stock price is €1.27. Accelerate Diagnostics's E10 for the quarter that ended in Sep. 2024 was €-11.83. Accelerate Diagnostics's Shiller PE Ratio of today is .


Accelerate Diagnostics E10 Historical Data

The historical data trend for Accelerate Diagnostics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics E10 Chart

Accelerate Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.85 -8.20 -10.14 -10.76 -12.49

Accelerate Diagnostics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.61 -12.49 -12.52 -11.90 -11.83

Competitive Comparison of Accelerate Diagnostics's E10

For the Medical Devices subindustry, Accelerate Diagnostics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accelerate Diagnostics's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's Shiller PE Ratio falls into.



Accelerate Diagnostics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Accelerate Diagnostics's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.532/133.0289*133.0289
=-0.532

Current CPI (Sep. 2024) = 133.0289.

Accelerate Diagnostics Quarterly Data

per share eps CPI Adj_EPS
201412 -1.622 99.070 -2.178
201503 -1.848 99.621 -2.468
201506 -2.406 100.684 -3.179
201509 -2.227 100.392 -2.951
201512 -2.662 99.792 -3.549
201603 -2.604 100.470 -3.448
201606 -3.115 101.688 -4.075
201609 -3.029 101.861 -3.956
201612 -2.939 101.863 -3.838
201703 -2.524 102.862 -3.264
201706 -2.759 103.349 -3.551
201709 -2.601 104.136 -3.323
201712 -2.450 104.011 -3.134
201803 -3.001 105.290 -3.792
201806 -3.681 106.317 -4.606
201809 -3.514 106.507 -4.389
201812 -3.604 105.998 -4.523
201903 -3.540 107.251 -4.391
201906 -3.363 108.070 -4.140
201909 -3.360 108.329 -4.126
201912 -3.510 108.420 -4.307
202003 -3.529 108.902 -4.311
202006 -3.108 108.767 -3.801
202009 -2.802 109.815 -3.394
202012 -2.713 109.897 -3.284
202103 -3.444 111.754 -4.100
202106 -2.988 114.631 -3.468
202109 -1.275 115.734 -1.466
202112 -3.089 117.630 -3.493
202203 -1.816 121.301 -1.992
202206 -2.299 125.017 -2.446
202209 -1.848 125.227 -1.963
202212 -1.322 125.222 -1.404
202303 -1.597 127.348 -1.668
202306 -2.741 128.729 -2.833
202309 0.056 129.860 0.057
202312 -0.743 129.419 -0.764
202403 -0.681 131.776 -0.687
202406 -0.465 132.554 -0.467
202409 -0.532 133.029 -0.532

Add all the adjusted EPS together and divide 10 will get our e10.


Accelerate Diagnostics  (STU:1A80) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Accelerate Diagnostics E10 Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Accelerate Diagnostics Business Description

Traded in Other Exchanges
Address
3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Accelerate Diagnostics Headlines

No Headlines